Amarin Corporation

biopharmaceutical company

AMRN Nasdaq ISIN US0231114044 SEC CIK 897448
Follow Amarin Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $39.6M −20.4% vs same quarter last year
Net income $245K +103.2% vs same quarter last year
EPS, diluted $0.00 +100% vs same quarter last year
Operating cash flow $9.2M +172.6% vs same quarter last year
Revenue by quarter
$62.3M
$42M
$72.7M
$49.7M
$49.2M
$45.1M
$42.2M
$39.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400M$600M$800MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$213.6M−$38.8M
FY24$228.6M−$87M
FY23$306.9M−$55M
FY22$369.2M−$105.8M
FY21$583.2M$7.7M
FY20$614.1M−$18M
FY19$429.8M−$22.6M
FY18$229.2M−$116.4M
FY17$181.1M−$67.9M
FY16$130.1M−$86.4M
FY15$81.8M−$115.2M
FY14$54.2M−$56.4M
FY13$26.4M−$166.2M
FY12-−$179.2M
FY11-−$69.1M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−800%−600%−400%−200%0%200%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2556.6%−23.5%−18.2%
FY2435.6%−40.2%−38.1%
FY2353.9%−22%−17.9%
FY2265.7%−28.7%−28.7%
FY2179.2%1.8%1.3%
FY2078.6%−3.2%−2.9%
FY1977.7%−5.6%−5.3%
FY1876.2%−47.2%−50.8%
FY1775.2%−25.2%−37.5%
FY1673.6%−50.4%−66.4%
FY1565.9%−120.1%−140.9%
FY1462.2%−177%−104%
FY1354.8%−691.1%−630.8%
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22-
FY21-
FY20−$22M
FY19−$11.8M
FY18−$94.8M
FY17−$32.8M
FY16−$71.8M
FY15−$84M
FY14-
FY13−$190.4M
FY12−$122.9M
FY11−$39.8M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Amarin
  • Healthcare median
−800%−600%−400%−200%0%200%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAmarinHealthcare median
FY25−18.2%−30.6%
FY24−38.1%−47%
FY23−17.9%−58%
FY22−28.7%−80.4%
FY211.3%−71.8%
FY20−2.9%−62.2%
FY19−5.3%−46.2%
FY18−50.8%−49.6%
FY17−37.5%−45.9%
FY16−66.4%−36%
FY15−140.9%−37.8%
FY14−104%−35.5%
FY13−630.8%−37.1%
FY12-−29.1%
FY11-−27.9%